Literature DB >> 3609055

Quantitative assessment of thallium myocardial washout rate: importance of peak heart rate and lung thallium uptake in defining normal values.

T Nishimura, T Uehara, K Hayashida, T Kozuka, M Saito, T Sumiyoshi.   

Abstract

Traditionally, the results of exercise thallium scintigraphy were interpreted by transient defect analysis using initial and delayed images. Recently, washout rate analysis has been used for the relative quantification of exercise thallium scintigraphy. A diffuse slow washout from all myocardial regions has been defined as the indicator of extensive coronary artery disease. However, slow washout has occasionally been observed in normal cases and in healthy myocardial segments which are not supplied by a stenosed artery in patients with single or double vessel disease. We evaluate the factors influencing washout rate in 100 normal patients and 63 patients with angina pectoris (33 cases of single vessel disease and 30 cases of double vessel disease). The washout rates were calculated using circumferential profile analysis. In normal patients, washout rate was closely related to peak heart rate (r = 0.72) and inversely related to lung thallium uptake (r = -0.56). A diffuse slow washout was observed in seven (7%) of 100 normal patients, six (18%) of 33 cases of single vessel disease and eight (24%) of 30 cases of double vessel disease. The patients with diffuse slow washout showed significantly higher lung thallium uptake values and lower peak heart rates than those without diffuse slow washout (P less than 0.01). Thus, this false positive slow washout should be considered in the interpretation of quantitative exercise thallium scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3609055     DOI: 10.1007/bf00256018

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  15 in total

1.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

2.  Slow regional clearance of myocardial thallium-201 in the absence of perfusion defect: contribution to detection of individual coronary artery stenoses and mechanism for occurrence.

Authors:  A Abdulla; J Maddahi; E Garcia; A Rozanski; H J Swan; D S Berman
Journal:  Circulation       Date:  1985-01       Impact factor: 29.690

3.  Spatial and temporal quantitation of plane thallium myocardial images.

Authors:  D D Watson; N P Campbell; E K Read; R S Gibson; C D Teates; G A Beller
Journal:  J Nucl Med       Date:  1981-07       Impact factor: 10.057

4.  Lung thallium-201 uptake after stress testing in patients with coronary artery disease.

Authors:  F G Kushner; R D Okada; H D Kirshenbaum; C A Boucher; H W Strauss; G M Pohost
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

5.  Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201.

Authors:  G M Pohost; L M Zir; R H Moore; K A McKusick; T E Guiney; G A Beller
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

6.  Exercise thallium-201 myocardial imaging in left main coronary artery disease: sensitive but not specific.

Authors:  T Rehn; L S Griffith; S C Achuff; I K Bailey; B H Bulkley; R Burow; B Pitt; L C Becker
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

7.  Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: comparison with patients with multiple- and single-vessel coronary artery disease.

Authors:  T W Nygaard; R S Gibson; J M Ryan; J A Gascho; D D Watson; G A Beller
Journal:  Am J Cardiol       Date:  1984-02-01       Impact factor: 2.778

8.  Quantification of pulmonary thallium-201 activity after upright exercise in normal persons: importance of peak heart rate and propranolol usage in defining normal values.

Authors:  K A Brown; C A Boucher; R D Okada; H W Strauss; G M Pohost
Journal:  Am J Cardiol       Date:  1984-06-01       Impact factor: 2.778

9.  Influence of coronary artery disease on pulmonary uptake of thallium-201.

Authors:  J B Bingham; K A McKusick; H W Strauss; C A Boucher; G M Pohost
Journal:  Am J Cardiol       Date:  1980-11       Impact factor: 2.778

10.  Space/time quantitation of thallium-201 myocardial scintigraphy.

Authors:  E Garcia; J Maddahi; D Berman; A Waxman
Journal:  J Nucl Med       Date:  1981-04       Impact factor: 10.057

View more
  6 in total

Review 1.  The use of thallium-201 lung/heart ratios.

Authors:  S Mahmood; J R Buscombe; P J Ell
Journal:  Eur J Nucl Med       Date:  1992

2.  Methods of calculating 123I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy.

Authors:  Zhuoqing Chen; Kenichi Nakajima; Ken-Ichi Hirano; Takashi Kamiya; Shohei Yoshida; Shintaro Saito; Seigo Kinuya
Journal:  Ann Nucl Med       Date:  2022-09-25       Impact factor: 2.258

3.  Prediction of multivessel coronary artery disease and candidates for stress-only imaging using multivariable models with myocardial perfusion imaging.

Authors:  Yuji Kunita; Kenichi Nakajima; Tomoaki Nakata; Takashi Kudo; Seigo Kinuya
Journal:  Ann Nucl Med       Date:  2022-06-05       Impact factor: 2.258

4.  Exercise thallium scintigraphy in aortitis syndrome (Takayasu's arteritis).

Authors:  T Nishimura; T Matsuo; T Uehara; K Hayashida; T Kozuka; R Nakayama
Journal:  Eur J Nucl Med       Date:  1990

5.  Prognostic utility of sestamibi lung uptake does not require adjustment for stress-related variables: a retrospective cohort study.

Authors:  William D Leslie; Marina S Yogendran; Linda M Ward; Khaled A Nour; Colleen J Metge
Journal:  BMC Nucl Med       Date:  2006-03-29

6.  Accuracy of washout rate analysis for thallium-201 single-photon emission computed tomography myocardial perfusion imaging using cadmium zinc telluride detectors: A phantom study.

Authors:  Masaru Ishihara; Masahisa Onoguchi; Takayuki Shibutani
Journal:  JRSM Cardiovasc Dis       Date:  2020-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.